human | Q5 |
P496 | ORCID iD | 0000-0002-8237-0106 |
0000-0002-0002-1544 | ||
P1153 | Scopus author ID | 47761916600 |
7202818565 |
P69 | educated at | Queensland University of Technology | Q1144750 |
University of Notre Dame Australia | Q1887921 | ||
P108 | employer | University of the Sunshine Coast | Q1423677 |
P734 | family name | Pearson | Q2065931 |
Pearson | Q2065931 | ||
Pearson | Q2065931 | ||
P735 | given name | Mark | Q13610143 |
Mark | Q13610143 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q51730343 | A novel blood-feeding detoxification pathway in Nippostrongylus brasiliensis L3 reveals a potential checkpoint for arresting hookworm development. |
Q37326963 | An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection |
Q28541675 | An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas |
Q33350965 | Asparaginyl endopeptidase from the carcinogenic liver fluke, Opisthorchis viverrini, and its potential for serodiagnosis |
Q37756146 | Blunting the knife: development of vaccines targeting digestive proteases of blood-feeding helminth parasites |
Q112739580 | Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers |
Q39164734 | Complete mitochondrial genomes confirm the distinctiveness of the horse-dog and sheep-dog strains of Echinococcus granulosus. |
Q37800361 | Developing vaccines to combat hookworm infection and intestinal schistosomiasis |
Q34201141 | Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. |
Q55279724 | Flatworm-specific transcriptional regulators promote the specification of tegumental progenitors in Schistosoma mansoni. |
Q33225325 | Identification of membrane-bound and secreted proteins from Echinococcus granulosus by signal sequence trap |
Q47950648 | Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria |
Q39345444 | In vitro and in silico analysis of signal peptides from the human blood fluke, Schistosoma mansoni |
Q64927142 | In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination. |
Q38022339 | Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines |
Q108819134 | Monoclonal Antibodies Targeting an Opisthorchis viverrini Extracellular Vesicle Tetraspanin Protect Hamsters against Challenge Infection |
Q28485406 | Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control |
Q43109540 | Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis |
Q35887080 | New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74 |
Q91757247 | Novel cholinesterase paralogs of Schistosoma mansoni have perceived roles in cholinergic signalling and drug detoxification and are essential for parasite survival |
Q37196249 | Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificity |
Q34442381 | Peptide-based subunit vaccine against hookworm infection |
Q47310292 | Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases |
Q42162237 | Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus |
Q98156126 | Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis |
Q42220033 | Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice |
Q36707894 | Schistosome membrane proteins as vaccines |
Q27681356 | Solution Structure, Membrane Interactions, and Protein Binding Partners of the Tetraspanin Sm-TSP-2, a Vaccine Antigen from the Human Blood FlukeSchistosoma mansoni |
Q59278433 | Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis |
Q36827558 | The parasite's new clothes |
Q46234830 | Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice |
Search more.